Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4389600 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL11456210 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL23877975 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL9352903 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL9352914 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL17526482 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL12403853 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL11322979 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL21437009 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 | |
| SCHEMBL9398533 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751972-B2 | Thermally stable biuret and isocyanurate based surface modifying macromolecules and uses thereof | Interface Biologic Inc. (CA) | 2017-09-05 | — | — | US | disclosed |
| US-20150025198-A1 | THERMALLY STABLE BIURET AND ISOCYANURATE BASED SURFACE MODIFYING MACROMOLECULES AND USES THEREOF | INTERFACE BIOLOGICS INC. (CA) | 2015-01-22 | — | — | US | disclosed |
| US-8318867-B2 | Thermally stable biuret and isocyanurate based surface modifying macromolecules and uses thereof | INTERFACE BIOLOGICS, INC. (CA) | 2012-11-27 | — | — | US | disclosed |
| US-20120148774-A1 | THERMALLY STABLE BIURET AND ISOCYANURATE BASED SURFACE MODIFYING MACROMOLECULES AND USES THEREOF | INTERFACE BIOLOGICS INC. (CA) | 2012-06-14 | — | — | US | disclosed |
| US-8178620-B2 | Surface modifying macromolecules with high degradation temperatures and uses thereof | INTERFACE BIOLOGICS INC. (CA) | 2012-05-15 | — | — | US | disclosed |
| US-8071683-B2 | Surface modifying macromolecules with high degradation temperatures and uses thereof | INTERFACE BIOLOGICS INC. (CA) | 2011-12-06 | — | — | US | disclosed |
| US-20110271961-A1 | SURFACE MODIFYING MACROMOLECULES WITH HIGH DEGRADATION TEMPERATURES AND USES THEREOF | INTERFACE BIOLOGICS INC. (CA) | 2011-11-10 | — | — | US | disclosed |
| US-20110207893-A1 | THERMALLY STABLE BIURET AND ISOCYANURATE BASED SURFACE MODIFYING MACROMOLECULES AND USES THEREOF | INTERFACE BIOLOGIS INC. (CA) | 2011-08-25 | — | — | US | disclosed |
| US-20080228253-A1 | Surface modifying macromolecules with high degradation temperatures and uses thereof | Evonik Canada Inc. (CA) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207893-A1 | THERMALLY STABLE BIURET AND ISOCYANURATE BASED SURFACE MODIFYING MACROMOLECULES AND USES THEREOF | INMT, BHMT, B2M | ALDH1A1 373/4885LMNA 2402/4885TSHR 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.